# Actelis Networks Inc: overview ASNS · OTC · CIK 1141284 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/asns.md) · [Financials](/companies/asns/financials.md) · [Filings](/companies/asns/filings.md) · [Insiders](/companies/asns/insiders.md) Latest reported revenue: [$1.1m](/filings/0001213900-26-089172.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 13, 2026 (XBRL us-gaap:Revenues, accession 0001213900-26-089172). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [2,541](/filings/0001213900-25-110375.md) | [1,062 d](/filings/0001213900-26-030942.md) | [721](/filings/0001213900-26-056772.md) | [941](/filings/0001213900-26-089172.md) | [643](/filings/0001213900-25-110375.md) | [1,366 d](/filings/0001213900-26-030942.md) | [958](/filings/0001213900-26-056772.md) | [1,132](/filings/0001213900-26-089172.md) | | Gross margin | % | [68.6%](/filings/0001213900-25-110375.md) | [34.3% d](/filings/0001213900-26-030942.md) | [34.8%](/filings/0001213900-26-056772.md) | [32.4%](/filings/0001213900-26-089172.md) | [28.5%](/filings/0001213900-25-110375.md) | [35.1% d](/filings/0001213900-26-030942.md) | [24.5%](/filings/0001213900-26-056772.md) | [51.1%](/filings/0001213900-26-089172.md) | | Operating margin | % | [(12.5%)](/filings/0001213900-25-110375.md) | [(154.0%) d](/filings/0001213900-26-030942.md) | [(251.3%)](/filings/0001213900-26-056772.md) | [(188.4%)](/filings/0001213900-26-089172.md) | [(300.0%)](/filings/0001213900-25-110375.md) | [(122.3%) d](/filings/0001213900-26-030942.md) | [(194.5%)](/filings/0001213900-26-056772.md) | [(139.8%)](/filings/0001213900-26-089172.md) | | Net margin | % | [(20.1%)](/filings/0001213900-25-110375.md) | [(169.4%) d](/filings/0001213900-26-030942.md) | [(258.0%)](/filings/0001213900-26-056772.md) | [(202.0%)](/filings/0001213900-26-089172.md) | [(307.9%)](/filings/0001213900-25-110375.md) | [(184.5%) d](/filings/0001213900-26-030942.md) | [(256.4%)](/filings/0001213900-26-056772.md) | [(123.1%)](/filings/0001213900-26-089172.md) | | Diluted EPS | $ per share | [(0.09)](/filings/0001213900-25-110375.md) | not reported | [(2.18)](/filings/0001213900-26-056772.md) | [(2.08)](/filings/0001213900-26-089172.md) | [(0.17)](/filings/0001213900-25-110375.md) | not reported | [(0.16)](/filings/0001213900-26-056772.md) | [(0.05)](/filings/0001213900-26-089172.md) | | Free cash flow | $k | [(2,438) d](/filings/0001213900-25-110375.md) | [(1,768) d](/filings/0001213900-26-030942.md) | not reported | not reported | [(2,419) d](/filings/0001213900-25-110375.md) | [(2,058) d](/filings/0001213900-26-030942.md) | [(1,947)](/filings/0001213900-26-056772.md) | [(1,780) d](/filings/0001213900-26-089172.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [8,545](/filings/0001213900-23-024106.md) | [8,831](/filings/0001213900-24-026069.md) | [5,606](/filings/0001013762-25-001251.md) | [7,760](/filings/0001213900-26-030942.md) | [3,671](/filings/0001213900-26-030942.md) | | Gross margin | % | [46.5%](/filings/0001213900-23-024106.md) | [46.5%](/filings/0001213900-24-026069.md) | [33.9%](/filings/0001013762-25-001251.md) | [55.0%](/filings/0001213900-26-030942.md) | [33.2%](/filings/0001213900-26-030942.md) | | Operating margin | % | [(21.8%)](/filings/0001213900-23-024106.md) | [(69.1%)](/filings/0001213900-24-026069.md) | [(131.3%)](/filings/0001013762-25-001251.md) | [(48.4%)](/filings/0001213900-26-030942.md) | [(195.7%)](/filings/0001213900-26-030942.md) | | Net margin | % | [(61.5%)](/filings/0001213900-23-024106.md) | [(124.4%)](/filings/0001213900-24-026069.md) | [(112.1%)](/filings/0001013762-25-001251.md) | [(56.4%)](/filings/0001213900-26-030942.md) | [(225.0%)](/filings/0001213900-26-030942.md) | | Diluted EPS | $ per share | [(2.56)](/filings/0001213900-23-024106.md) | [(9.45)](/filings/0001213900-24-026069.md) | [(2.61)](/filings/0001013762-25-001251.md) | [(8.50)](/filings/0001213900-26-030942.md) | [(5.68)](/filings/0001213900-26-030942.md) | | Free cash flow | $k | [(2,780)](/filings/0001213900-23-024106.md) | not reported | [(6,586)](/filings/0001013762-25-001251.md) | [(6,550)](/filings/0001213900-26-030942.md) | [(7,700)](/filings/0001213900-26-030942.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/asns/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Cygnus Capital Advisors, LLC](/funds/2114319.md) | 2026-03-31 | $8 | 20,118 | | Not compared | ## Recent filings [All 340 filings](/companies/asns/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-15 | 21:00 ET | [8-K](/filings/0001213900-26-109880.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-109880 | | 2026-08-25 | 20:30 ET | [8-K](/filings/0001213900-26-093540.md) | 5.07 Shareholder vote results | 0001213900-26-093540 | | 2026-08-13 | 21:16 ET | [8-K](/filings/0001213900-26-089246.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-089246 | | 2026-08-13 | 20:38 ET | [10-Q](/filings/0001213900-26-089172.md) | Quarterly report, period 2026-06-30 | 0001213900-26-089172 | | 2026-07-29 | 20:30 ET | [8-K](/filings/0001213900-26-082835.md) | 8.01 Other events | 0001213900-26-082835 | | 2026-07-16 | 20:01 ET | [DEF 14A](/filings/0001213900-26-078692.md) | Proxy statement, period 2026-08-25 | 0001213900-26-078692 | | 2026-07-13 | 21:00 ET | [8-K](/filings/0001213900-26-077619.md) | 3.01 Delisting notice | 0001213900-26-077619 | | 2026-07-01 | 21:21 ET | [S-1](/filings/0001213900-26-074416.md) | Registration statement | 0001213900-26-074416 | | 2026-07-01 | 20:53 ET | [8-K](/filings/0001213900-26-074365.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-26-074365 | | 2026-07-01 | 20:29 ET | [8-K](/filings/0001213900-26-074300.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-074300 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001213900-26-030942.md), filed Mar 18, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/61af2253-a146-4d6f-ab24-0ab1b571b493) ## About the filer - CIK: 1141284 - Tickers: ASNS - Exchange: OTC - SIC code: 3669 Communications Equipment, NEC - State of incorporation: DE - Filer category:
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.